Steven J Yakubov MD

Adult Congenital Heart Disease, Interventional Cardiology

John H McConnell Chair of Advanced Structural Heart Disease System Chief, Structural Heart Disease

3705 Olentangy River RdSte 100Columbus, OH 43214
Phone+1 614-262-6772
Fax+1 614-447-2752

Dr. Yakubov is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Yakubov's full profile Already have an account?

Education & Training

University of MichiganFellowship, Cardiovascular Disease, 1989 - 1991
OhioHealth/Riverside Methodist HospitalResidency, Internal Medicine, 1985 - 1989
Northeast Ohio Medical UniversityClass of 1985

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

OH State Medical License 1986 - 2027
MI State Medical License 1989 - 1993
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
CMS Meaningful Use Stage 1 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2016-2017

Clinical Trials

IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction
COMPLETED
NA
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
COMPLETED
NA
The OMEGA Clinical Trial
COMPLETED
NA

Publications & Presentations

PubMed

Core-Laboratory Evaluation of Implantation Depth and Clinical Outcomes in TAVR: Optimize PRO Study.
Danny Dvir, Hasan A Jilaihawi, Douglas Fraser, Josep Rodés-Cabau, Tamim Nazif
JACC. Cardiovascular Interventions. 2026-08-10
Isolated Transcatheter and Surgical Aortic Valve Replacement in the Evolut Low-Risk Trial: 5-Year Comparative Outcomes.
Basel Ramlawi, G Michael Deeb, Steven J Yakubov, Mubashir Mumtaz, Michael W A Chu
The Annals of Thoracic Surgery. 2026-07-01
7 citations
Six-Year Outcomes After Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.
John K Forrest, Steven J Yakubov, G Michael Deeb, Michael J Reardon,
Journal of the American College of Cardiology. 2026-06-16

Journal Articles

Original Research Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Low-Gradient Aortic Stenosis
Harold L Dauerman, Jon R Resar, Steven J Yakubov, P Michael Grossman, Stanley J Chetcuti, G Michael Deeb, Jeffrey J Popma, Jae K Oh, ScienceDirect
Original Investigation Self-Expanding Transcatheter Aortic Valve Replacement or Surgical Valve Replacement in High-Risk Patients: 5-Year Outcomes
G Michael Deeb, Steven J Yakubov, Joon S Lee, Thomas G Gleason, William Merhi, George Petrossian, G Chad Hughes, David H Adams, Neal S Kleiman, Jeffrey J Popma, Mubash..., ScienceDirect

Lectures

Unmet Clinical Needs for Tricuspid Valve Interventions
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019
Evaluation for Conduction Disorders
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019
Ultrathin Orsiro: Where It Can Go
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019

Press Mentions

LuX-Valve TTVR Device Provides Favorable 1-Year ResultsApril 24th, 2025
Better 5-Year Valve Performance with TAVI Than SurgeryMarch 20th, 2025
TAVR Linked to Stronger Valve Performance Than SAVR in New 5-Year StudyMarch 10th, 2025